Exciting collaboration! 🚀 We’re excited to invite you to an exclusive sit-down conversation with another leader in the medtech space, JOGO Health – an innovative AI-powered health monitoring platform – with special guest moderator Deena Kuruvilla, MD, board-certified neurologist and headache specialist. 🔍 Join us as we deep dive into how we’re addressing critical healthcare challenges and our plans to transform the future of healthcare. Plus, we’ll be answering all your questions LIVE. 📅 Date: Thursday, July 25th 🕐 Time: 10am PT / 1pm ET 👥 Who: Conor Cullinane, PhD Cullinane (Founder & CEO, Pirouette), Sanjai Murali (Co-founder, JOGO Health), and board-certified neurologist & headache specialist, Dr. Deena Kuruvilla, MD 📍 Where: Zoom Webinar Don't miss this opportunity to explore the intersection of MedTech and AI in healthcare. Space is limited, so secure your spot now! → https://lnkd.in/gXe7wU-P
Pirouette Medical
Pharmaceutical Manufacturing
Portsmouth, New Hampshire 903 followers
Injections as easy as pushing a button!
About us
Injections as easy as pushing a button.
- Website
-
http://www.pirouettemedical.com/invest
External link for Pirouette Medical
- Industry
- Pharmaceutical Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Portsmouth, New Hampshire
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Pharmaceuticals, Medical Devices, Naloxone, Opioid Use Disorder, Anaphylaxis, and Auto-Injectors
Locations
-
Primary
200 International Dr
Portsmouth, New Hampshire 03801, US
Employees at Pirouette Medical
-
Thomas Mueller, MSIS
former Chief Data Officer (CDO) ● Data & Analytics Director ● visionary executive leader ● principal consultant ● early-stage investor ● LEGO®…
-
Matthew K. Fox
CoS | Customer-Centric Leader | Entrepreneur | Ironman | Mentor | Angel
-
Jacob Rodriguez
Mechanical Design Engineer
-
Aadesh Gindodiya
UN Principles for Responsible Investment | ESG & Sustainable Finance | Angel Investor | Management Consultant | Board Member | Ex-GLG, Asia News
Updates
-
Pirouette Medical reposted this
“The biggest learning for me and the biggest excitement with the community round is every time somebody invests, there's a little box where they get to put in information about why they're investing. Some folks don't say anything, but a lot of them do. It's been so rewarding for me to read through those comments and just hear the stories about family members and loved ones who see how they could use our technology.” Meet Conor Cullinane, PhD, an aeronautical engineer by training who went from designing NASA space suits to developing novel #medicaldevices. Conor has an impressive resume that includes Harvard Medical School, Massachusetts Institute of Technology, and NASA - National Aeronautics and Space Administration. He, along with two other rocket scientists, co-founded Pirouette Medical, a startup developing Quicpush, a disk-shaped autoinjector that delivers medicines with just the push of a button. Here’s a sneak peek into Conor’s conversation with Scott Nelson: 📐 Be selective with where you innovate. Disrupt where it matters most, but don't reinvent the wheel unnecessarily. By aligning with established practices and industry standards, you can streamline your development processes, reduce costs, and ultimately leave room for creative freedom where it counts. 🔄 Although less common in medtech, community fundraising rounds may offer benefits like brand awareness and direct engagement with potential end users. View all investors as valued partners to foster a strong community and feedback loop around your product. 👓 Everyone in the healthcare supply chain, from payers to providers, needs a reason to choose your product. To successfully launch a #medicaldevice, it's crucial to understand the needs of all stakeholders. Check out the full interview link with Conor in the comments below. This Medsider episode was brought to you by FastWave Medical, a hot IVL startup in the cardiovascular space. Don’t miss out on their next fundraise (more details in the comments). P.S. - We just launched Medsider Mentors Volume VI, which is packed with insights and learnings from founders and CEOs of some of the most dynamic medical device and health technology startups in the world. Click the link in the comment section for this latest edition now available exclusively to our premium members.
-
Exciting news! The response to Pirouette’s community round on Wefunder has been incredible and we have now officially raised over $1,000,000! This also brings us to $5M+ raised in total this round. If you’ve been considering investing or sharing our campaign, now is the time. Our round is filling up quickly. Learn more at wefunder.com/pirouette Safar Partners Gaingels Joseph M. Nemmers Jr. Y Combinator KINGSCROWD Capital Liquid 2 Ventures
-
It’s an exciting time here at Pirouette HQ! We just received a Notice of Award from the NIH – they have awarded us an administrative supplement of $97K+ to expand the scope of our Phase I award! 💸🔬 The Phase I award has been crucial in affirming the technical merit and commercial potential of our Naloxone HCl auto-injector. With this expanding scope, we can accelerate our progress toward FDA approval and commercialization, bringing us closer to saving lives. 🙌 NIH SEED https://lnkd.in/epgze9eF
-
Pirouette Medical reposted this
Thanks to Olivia Strobl for putting together some company overview slides for KINGSCROWD's Demo Day, tomorrow at 12pm ET! Take a swipe through our presenting company details and consider joining us tomorrow with the link below 👇 Register: https://lnkd.in/e4UpGHZv
-
Join us at BIO 2024, June 3-6 in San Diego, where will be showcasing our innovative auto-injector aimed at revolutionizing the end-user and patient experience when administering an injection. Come see how we're reimagining injections. Find us at Booth 825 - the NIH SEED Innovation Zone. See you there! #BIO2024
I'm excited to be attending #bio2024 in San Diego along with 45 cutting edge life science innovators, all of whom have built their products in part with non-dilutive funds given by one of the 24 Institutes of the #NIH. Of these, 30 will be with me at booth #825. These are all companies now looking for venture investment, #pharma partners, and/or strategic relationships -- and it's fair to say that having been selected for our Showcase program, they are all poised to improve the standard of care across their sectors. I'll share the names of these 30 below. If you'd like our team to put together introductions specific to your area of interest, please DM me. Regardless of what you may be looking for, there's a good chance one or more of these companies fits your checklist. AAVogen Accuronix Therapeutics, Inc. Biopico Systems INC Concerto Biosciences DermaXon Extend Biosciences, Inc. Lectenz Bio GSNO Therapeutics Hillhurst Biopharmaceuticals, Inc. Immuto Scientific Indee Labs Invivo Science International Inc Kannalife, Inc. KayoThera Lynthera Corporation Medosome Biotec Modality.AI Devine Biosystems Novoron Bioscience Pelagos Pharma Pirouette Medical Reveal Pharmaceuticals Sinopia Biosciences Sacromatrix Talus Bio Tiba Biotech TransCode Therapeutics, Inc. Ventrix Vivacelle Bio, Inc. Buel D. (a.k.a. Dan) Rodgers Bradley Keller John Collins Philippe Diaz Tarik S. Lori Yang Andrew Gomperts Faraz A. Choudhury, Ph.D. ryan P. Ayla Annac Dean Petkanas Merika Koday, PhD Jeff Yang David R. Craig, MBA Conor Cullinane, PhD
-
More Great News from BIO 2024! 🌟 We’re excited to announce that we have been invited to present for a second time at the BIO conference, this time at the NIH booth! This is an incredible opportunity to further highlight Pirouette’s patented autoinjector technology. We are grateful for the support and partnership of the NIH SEED in our journey to make life-saving injections as easy as pushing a button. Let’s make a difference together! #BIO2024 #MedTech #NIH
-
I’m proud to share that Pirouette has been invited to participate in the Food Allergy Fund Summit on May 23 in New York City! I'll be joining other industry leaders for a panel discussion on emerging solutions in the field where we’ll highlight our Epinephrine auto-injector. 📅 Date: Thursday, May 23 📍 Location: Paley Center for Media, NYC. 👥 Event: Panel on innovative food allergy solutions ft. Pirouette If you're in the area, we'd love for you to join us! Please follow the link in the comments below to register to attend. Hope to see you there!
-
We’re honored to be recognized as an NIH SEED Innovation Company! Pirouette was selected out of hundreds of companies to represent the NIH at BIO 2024, underscoring our dedication to healthcare advancement. It is so exciting to be recognized as one of the top companies with NIH support. This is a fantastic platform to demonstrate how we're transforming the future of injections, especially when it comes to addressing the opioid overdose epidemic. We look forward to presenting and connecting with industry leaders. ⚕️ Thank you to the NIH for your continued support! #BIO2024 #MedTech #NIH